Authors

Peter Wehrwein
Recent : Researchers: Ancillary Services Would Comprise 20% of Medicare Spending on Aduhelm
Formulary Watch
Recent : FDA Approves Breyanzi for Additional Indication in Large B-Cell Lymphoma
Timothy P. Gauthier, PharmD, BCPS
Recent : Antimicrobial stewardship programs-A review for the formulary decision-maker
Rosanna Sutherby, Pharm.D.
Recent : GlaxoSmithKline Halts RSV Vaccine Trials in Pregnant Women
Laura Joszt, MA
Recent : Employers Face Barriers With Adopting Biosimilars

Laura Joszt, MA, is a vice president of content at MJH Life Sciences

Jennifer Gershman, Pharm.D., CPh
Recent : Second mRNA COVID-19 Vaccine in Primary Series Can Be Extended to 8 Weeks for Some Individuals
Denise Myshko
Recent : Survey: Patient Satisfaction is a Barrier to Utilization Management of Drug Plans

Denise Myshko is your editorial contact for the Formulary Watch. She joined Formulary Watch as editor is June 2021 from Oncology Live. Prior to that, she was managing editor of PharmaVOICE, a trade publication in the pharmaceutical industry. Email: dmyshko@mjhlifesciences.com

Nathan R. Unger, PharmD
Recent : Antimicrobial stewardship programs-A review for the formulary decision-maker
Briana Contreras
Recent : Best Read Articles on Safety Issues and Recalls in 2021
Christine Blank
Recent : FDA Expands EUA for Moderna, Pfizer-BioNTech COVID-19 Vaccines to Children 6 Months and Up